He's already responded re: cash.
And I don't see why it's important for him to buy shares. And it's certainly not fair to place that pressure.
He can do what he wishes with his money.
And I don't see how you know anything about the contract and what can and cannot be disclosed.
Remember there was an Ann a few months back where neu effectively had to plead with Acadia to allow them to release info.
You don't want this trial stuffed up because one shareholder feels like he lacks clarity.
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren to capture substantially greater value after Phase 3
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.23%
!
$13.27

Ann: Neuren to capture substantially greater value after Phase 3, page-80
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.27 |
Change
0.415(3.23%) |
Mkt cap ! $1.626B |
Open | High | Low | Value | Volume |
$13.15 | $13.34 | $12.92 | $3.370M | 257.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 69 | $13.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.28 | 339 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 147 | 13.260 |
6 | 255 | 13.250 |
10 | 687 | 13.240 |
5 | 611 | 13.230 |
7 | 1529 | 13.220 |
Price($) | Vol. | No. |
---|---|---|
13.280 | 339 | 8 |
13.290 | 334 | 2 |
13.300 | 444 | 3 |
13.310 | 615 | 4 |
13.320 | 1202 | 4 |
Last trade - 11.28am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online